Dr. Przemysław Koźmiński, Ph.D., holds the position of Adjunct Professor at the Institute of Nuclear Chemistry and Technology (INCT). He earned his Master of Science degree from the Faculty of Chemistry at the University of Warsaw in 2004 and subsequently obtained his Doctorate from the Centre for Radiochemistry and Nuclear Chemistry at the Institute of Nuclear Chemistry and Technology in 2012. His research predominantly focuses on the design of radiopharmaceuticals for nuclear medicine, with particular emphasis on the synthesis and evaluation of novel radiotracers for disease imaging and therapeutic applications, specifically concerning cancer and Alzheimer's disease.